Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe

Somatic gene editing (SGE) holds great promise for making genetic therapy possible for many monogenic conditions very soon. Is our current system of European market authorization and reimbursement ready for the expected tsunami of gene therapies? At a recent workshop of the Netherlands ZonMw consort...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigter, Tessel, Klein, David, Weinreich, Stephanie S., Cornel, Martina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484669/
https://www.ncbi.nlm.nih.gov/pubmed/33850300
http://dx.doi.org/10.1038/s41431-021-00877-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484669/
https://www.ncbi.nlm.nih.gov/pubmed/33850300
http://dx.doi.org/10.1038/s41431-021-00877-y

Ejemplares similares